Agenda
8:30 AM — 9:15 AM
10:45 AM — 11:15 AM
1:00 PM — 2:00 PM
2:00 PM — 3:00 PM
Session 3: Hospital Exemption and Implications for Drug Development3:00 PM — 4:15 PM
Session 4: Registries4:15 PM — 4:30 PM
9:00 AM — 10:45 AM
Session 5: The Pricing and Reimbursement Perspective10:45 AM — 11:15 AM
11:15 AM — 1:00 PM
Session 6: Pricing & HTA challenges for Cell and Gene Therapies1:00 PM — 1:45 PM
1:45 PM — 2:45 PM
Session 7: Case Study of an ATMP Launch in Europe2:45 PM — 3:00 PM
Closing Remarks¿Tiene una cuenta?